Conference News

Cancer Genomics Pioneer Honored by AMP

In her keynote lecture, Elaine R. Mardis, PhD, discussed advances in pediatric precision medicine and encouraged the expansion of data-sharing initiatives.

Share

Elaine R. Mardis, PhD, a leader in cancer genomics, was awarded the 2025 Award for Excellence in Molecular Diagnostics by the Association for Molecular Pathology (AMP) for her significant contributions to the field. During the AMP annual meeting in Boston, she presented a keynote lecture on the impact of genomics in pediatric precision medicine, emphasizing advancements in genomic sequencing and machine learning for diagnosing rare genetic diseases. Her research at Nationwide Children’s Hospital demonstrates the transformative potential of genomics in improving patient outcomes through timely interventions.

Original Source(s)

Cancer Genomics Pioneer Honored by AMP

In her keynote lecture, Elaine R. Mardis, PhD, discussed advances in pediatric precision medicine and encouraged the expansion of data-sharing initiatives.

  • by Jim Gallagher, senior managing editor

  • November 13, 2025

  • 4 min

Related Content

AI Models Predict CNS Tumors From Spinal Fluid

At AMP 2025, a South Korean research team outlined a multimodal approach that integrates CSF, DNA, and MRI data to enable early, noninvasive tumor classification.

New Genetic Test Targets Rare X-Linked Movement Disorder

A targeted assay, presented at AMP 2025, identifies disease-specific TAF1 variants that standard panels often miss.

Artificial Intelligence in Health Care: The Ethical Frontier

At AMP 2025, Takunda Matose, PhD, urged pathologists to consider the limitations of big data and probabilistic reasoning to maximize AI’s benefits for clinical outcomes.